Fig. 1From: The role of phosphodiesterase-5 inhibitors in prostatic inflammation: a reviewSchematic diagram showing the hypothetical mechanism of Phosphodiesterase 5 Inhibitors (PDE5Is) on prostatic inflammmation. PDE5Is can direct and indirectly down-regulate prostatic inflammation/BPH/LUTS by inducing high levels of cGMPBack to article page